Cause of death, by non-communicable diseases, ages 0-4 in Morocco
Morocco: Cause of death, by non-communicable diseases, ages 0-4 was 29.9% in 2021. ▲ Rising
Cause of death, by non-communicable diseases, ages 0-4 in Morocco, 2000–2021
Source: Global Health Estimates, World Health Organization (WHO). Measured in % of total deaths ages 0-4.
Analysis
In 2021, cause of death, by non-communicable diseases, ages 0-4 in Morocco stood at 29.9%. That is the highest value across all 6 years on record.
Compared with earlier readings it is up 2.1% on the previous year and up 80.8% over ten years.
Over the whole period, cause of death, by non-communicable diseases, ages 0-4 in Morocco peaked at 29.9% in 2021 and was at its lowest, 13.1%, in 2000.
Morocco ranks 98th of 185 countries on this measure, in the middle of the range.
Cause of death, by non-communicable diseases, ages 0-4 in Morocco, year by year
| Year | % of total deaths ages 0-4 | Change |
|---|---|---|
| 2000 | 13.1% | — |
| 2010 | 16.5% | +26.2% |
| 2015 | 23.9% | +44.4% |
| 2019 | 28.5% | +19.5% |
| 2020 | 29.3% | +2.7% |
| 2021 | 29.9% | +2.1% |
Morocco compared with similar countries
- Morocco's 29.9% is above the median for lower middle income countries, which is 12.2%, 2.5× the median. (47 countries reporting)
- Morocco's 29.9% is below the median for Middle East, North Africa, Afghanistan & Pakistan, which is 35.3%, 85% of the median. (23 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 13.1% | 13.1% | 13.1% | 1 |
| 2010s | 23.0% | 16.5% | 28.5% | 3 |
| 2020s | 29.6% | 29.3% | 29.9% | 2 |
Countries ranked near Morocco
More health data for Morocco
- Un projection of annual infant deaths, annual growth rate -1.91 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0.6655 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,240 deaths per 1,000 people (2090)
- Number of infants who die before age 1 925 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 3 (2018)
- Population ages 00-04, female, annual growth rate -1.13 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0396 units per person (2025)
- Population ages 00-04, male, annual growth rate -1.1 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is cause of death, by non-communicable diseases, ages 0-4 in Morocco?
- Cause of death, by non-communicable diseases, ages 0-4 in Morocco was 29.9% in 2021, according to Global Health Estimates, World Health Organization (WHO).
- What is the highest cause of death, by non-communicable diseases, ages 0-4 recorded in Morocco?
- The highest recorded value was 29.9% in 2021.
- What is the lowest cause of death, by non-communicable diseases, ages 0-4 recorded in Morocco?
- The lowest recorded value was 13.1% in 2000.
- How does Morocco rank for cause of death, by non-communicable diseases, ages 0-4?
- Morocco ranks 98th out of 185 countries with data for 2021.
- Is cause of death, by non-communicable diseases, ages 0-4 rising or falling in Morocco?
- Over the last ten years it is up 80.8%. The long-run trend across the full record is rising.
- Where does this Morocco data come from?
- The figures come from Global Health Estimates, World Health Organization (WHO), published as part of Cause of death, by non-communicable diseases, ages 0-4 (% of total deaths ages 0-4). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 6 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
Number of deaths ages 0-4 due to non-communicable diseases divided by number of all deaths ages 0-4, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.